As the regulatory bodies continue to demand greater and greater controls around the excipients and processing aides, RB is here to deliver to that elevated standard.
St. Louis, MO (PRWEB) May 25, 2016
Reliable Biopharmaceutical LLC announces the launch of Trehalose Dihydrate, NF/EP, complementing its other High Purity Low Endotoxin carbohydrates.
Trehalose is an alpha linked disaccharide consisting of two glucose units. Research on Trehalose has demonstrated its ability to sustain and preserve a wide array of biological molecules often utilized in cell culture applications and final formulation. As an approved ingredient in regulated products, it can be found in a variety of commercially available therapeutic products, including both injectable and solid dose forms.
“Trehalose is just the next product in a long list of targets to introduce to the market.” Said David Feldker, President/CEO of Reliable Biopharmaceutical LLC. “As the regulatory bodies continue to demand greater and greater controls around the excipients and processing aides, RB is here to deliver to that elevated standard.”
About Reliable Biopharmaceutical LLC
Founded in 1968, RB is an integrated developer and manufacturer of Active Pharmaceutical Ingredients (APIs) and High Purity Ingredients (HPIs) for pharmaceuticals and biologics. RB has established a strong position as a leading developer and manufacturer of complex generic injectable APIs, cGMP Buffers, and cGMP Processing Aids. The company has a number of DMFs that have been accepted by Regulatory Agencies and has more in various stages of development. RB's APIs are in leading generic injectable drugs that treat cancer, heart disease, hypertension, anxiety and other serious and life threatening illnesses. RB HPIs are critical processing aids for many of the world's leading pharmaceutical and biotechnology companies.